257 related articles for article (PubMed ID: 35649449)
1. Bacterially mediated drug delivery and therapeutics: Strategies and advancements.
Wu L; Bao F; Li L; Yin X; Hua Z
Adv Drug Deliv Rev; 2022 Aug; 187():114363. PubMed ID: 35649449
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered bacteria: a new frontier in targeted drug delivery.
Fooladi S; Rabiee N; Iravani S
J Mater Chem B; 2023 Nov; 11(42):10072-10087. PubMed ID: 37873584
[TBL] [Abstract][Full Text] [Related]
3. Progress of engineered bacteria for tumor therapy.
Fan JX; Niu MT; Qin YT; Sun YX; Zhang XZ
Adv Drug Deliv Rev; 2022 Jun; 185():114296. PubMed ID: 35439571
[TBL] [Abstract][Full Text] [Related]
4. Tweak to Treat: Reprograming Bacteria for Cancer Treatment.
Sieow BF; Wun KS; Yong WP; Hwang IY; Chang MW
Trends Cancer; 2021 May; 7(5):447-464. PubMed ID: 33303401
[TBL] [Abstract][Full Text] [Related]
5. Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics.
Chen Y; Liu X; Guo Y; Wang J; Zhang D; Mei Y; Shi J; Tan W; Zheng JH
Acta Biomater; 2021 Apr; 124():72-87. PubMed ID: 33561563
[TBL] [Abstract][Full Text] [Related]
6. Bioengineered and biohybrid bacteria-based systems for drug delivery.
Hosseinidoust Z; Mostaghaci B; Yasa O; Park BW; Singh AV; Sitti M
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):27-44. PubMed ID: 27641944
[TBL] [Abstract][Full Text] [Related]
7. Advancement of Engineered Bacteria for Orally Delivered Therapeutics.
Guo P; Wang S; Yue H; Zhang X; Ma G; Li X; Wei W
Small; 2023 Nov; 19(48):e2302702. PubMed ID: 37537714
[TBL] [Abstract][Full Text] [Related]
8. Development of bacteria as diagnostics and therapeutics by genetic engineering.
Lim D; Song M
J Microbiol; 2019 Aug; 57(8):637-643. PubMed ID: 31079333
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Bacteria for Therapeutics.
Vo P; Lee HM; Na D
J Microbiol Biotechnol; 2019 Jun; 29(6):845-855. PubMed ID: 31216840
[TBL] [Abstract][Full Text] [Related]
10. Engineering Diagnostic and Therapeutic Gut Bacteria.
Landry BP; Tabor JJ
Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052539
[TBL] [Abstract][Full Text] [Related]
11. Advances in Salmonella Typhimurium-based drug delivery system for cancer therapy.
Chen W; Zhu Y; Zhang Z; Sun X
Adv Drug Deliv Rev; 2022 Jun; 185():114295. PubMed ID: 35429576
[TBL] [Abstract][Full Text] [Related]
12. Dopamine Polymerization-Mediated Surface Functionalization toward Advanced Bacterial Therapeutics.
Wang L; Liu J
Acc Chem Res; 2024 Mar; 57(6):945-956. PubMed ID: 38422996
[TBL] [Abstract][Full Text] [Related]
13. Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.
Ozdemir T; Fedorec AJH; Danino T; Barnes CP
Cell Syst; 2018 Jul; 7(1):5-16. PubMed ID: 30048620
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic and bioinspired strategies for oral drug delivery.
Hu X; Yang G; Chen S; Luo S; Zhang J
Biomater Sci; 2020 Feb; 8(4):1020-1044. PubMed ID: 31621709
[TBL] [Abstract][Full Text] [Related]
15. Bacterial vectors and delivery systems in cancer therapy.
Gardlik R; Fruehauf JH
IDrugs; 2010 Oct; 13(10):701-6. PubMed ID: 20878592
[TBL] [Abstract][Full Text] [Related]
16. Beyond the Maze: Recent Advancements in Molecular and Cellular Tethered Drug Delivery Systems.
Singh D
Assay Drug Dev Technol; 2024; 22(4):203-215. PubMed ID: 38717194
[No Abstract] [Full Text] [Related]
17. Tumor-specific gene delivery using genetically engineered bacteria.
Theys J; Barbé S; Landuyt W; Nuyts S; Van Mellaert L; Wouters B; Anné J; Lambin P
Curr Gene Ther; 2003 Jun; 3(3):207-21. PubMed ID: 12762480
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-controllable engineered bacteria for cancer immunotherapy.
Abedi MH; Yao MS; Mittelstein DR; Bar-Zion A; Swift MB; Lee-Gosselin A; Barturen-Larrea P; Buss MT; Shapiro MG
Nat Commun; 2022 Mar; 13(1):1585. PubMed ID: 35332124
[TBL] [Abstract][Full Text] [Related]
19. Bacteria and bacterial derivatives as delivery carriers for immunotherapy.
Kang SR; Nguyen DH; Yoo SW; Min JJ
Adv Drug Deliv Rev; 2022 Feb; 181():114085. PubMed ID: 34933064
[TBL] [Abstract][Full Text] [Related]
20. Engineered Bacteria: General Overview as Therapeutic Agent and a Novel Drug Delivery System.
Patil PL; Gharat SK; Jadhav KR; Kadam VJ
Curr Pharm Biotechnol; 2023; 24(11):1351-1364. PubMed ID: 36545730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
